Re-entering the Dragon: GSK returns to China after 12 years in blood cancer drug push

1 month ago 15
Add to circle
What a difference 12 years make. In 2014 GlaxoSmithKline was fined £300m by a Chinese court for running a 'massive bribery network'.
Read Entire Article